Navigation Links
Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts
Date:2/1/2010

iving, mountain climbing, whitewater rafting and snow skiing -- could work as a behavioral reward. As the researchers pointed out, novelty does not involve medical treatment or side effects, and could be cheaper as well.

"Treatment programs implementing novel rewards targeted to those individuals that have high novelty/sensation seeking tendencies may offer addicts the opportunity (e.g., with vouchers) to participate in one of the activities mentioned previously in hopes of maintaining abstinence," wrote Reichel and Bevins.


'/>"/>

Contact: Public Affairs Office
public.affairs@apa.org
202-336-5700
American Psychological Association
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Weight Watchers(R) Expands Licensed Food Categories with Launch of New Baked Goods, Frozen Novelty and Cheese Products to Encourage a More Sensible Lifestyle
2. Turning metal black more than just a novelty
3. Natural Disaster Rescue Teams at Public Health Facilities Across the Country Learn from Katrina Failures
4. AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF
5. Impulsive eater? Remembering failures may help curb eating
6. Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures
7. Chemical come-on successfully lures lovesick lampreys to traps
8. Heart Transplant Failures More Likely in Poor, Minority Kids
9. Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success
10. Deadly stomach infection rising in community settings, Mayo Clinic study finds
11. Drug-free treatments offer hope for older people in pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Selma Tansey as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 members ... to present Selma with this important honor," said NAPW ...
(Date:6/1/2015)... June 01, 2015 Carson Energy also ... their investors IRA transactions. AdvantaIRA Trust, LLC is the ... the ability to fund positions using IRA’s does 2 ... on a project, even if there current cash position ... additional funding source for Carson and their investors to ...
(Date:6/1/2015)... Texas (PRWEB) June 01, 2015 Unlike most ... as three times for in-use periods compared to when the ... monthly rate whether the client uses the generator or not. ... availability and delivery in as little as a few hours ... desire to store a portable generator onsite. , “Even minor ...
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. She ... she thought it was just a part of getting older, ... that. After going to the doctor, she received a distressing ... what might happen to her. , Linda is not alone. ... disease each year. Valve disease involves damage to one or ...
(Date:6/1/2015)... The Muscular Dystrophy Association is ... participating in the sold out 2015 Bank of ... guaranteed entry by signing up through the organization's ... is limited. , This national endurance program includes ... abilities, and a supportive community of teammates, volunteers, ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) -- ... risk for heart disease, Canadian researchers say. ... which by itself is a risk factor for heart disease, ... workplace is an important occupational health issue, especially for younger ...
... veterans until old age, even as it influences others to be ... University of Florida study finds. The findings are ominous with ... the ongoing Iraq and Afghanistan wars on terror at a rate ... World War II, said UF sociologist Monika Ardelt. "The study ...
... Oct. 6, 2010 A set of proteins found in ... to diagnose Alzheimer,s disease, researchers at UT Southwestern Medical Center ... An analysis of the proteins, plus a clinical exam, proved ... accurate in ruling it out in people without the disease, ...
... Reporter , TUESDAY, Oct. 5 (HealthDay News) -- The ... room visits in the United States has tripled since ... dramatic increase in the likelihood of getting a CT ... injury-related conditions without a corresponding increase in the likelihood ...
... The National Institutes of Health has awarded a ... Florida and Tampa-based biotechnology company Saneron-CCEL Therapeutics, Inc., ... human umbilical cord blood cells (HUBC) into animal ... use the pre-clinical data to gain U.S. Food ...
... Center,s Breast Cancer Clinic program has earned a three-year ... Breast Centers (NAPBC), a program administered by the American ... cancer is managed by a team, and the combined ... Christopher O. Ruud, M.D., director of the Scott & ...
Cached Medicine News:Health News:Workplace Noise Tied to Heart Disease Risk 2Health News:Workplace Noise Tied to Heart Disease Risk 3Health News:UF study: Emotional effects of heavy combat can be lifelong for veterans 2Health News:UF study: Emotional effects of heavy combat can be lifelong for veterans 3Health News:Blood test could diagnose Alzheimer's disease, UT Southwestern researchers find 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 3Health News:USF and Saneron get $2.6 million to develop Alzheimer's treatment using umbilical cord blood cells 2Health News:Scott & White breast cancer program receives accreditation 2
(Date:6/2/2015)... June 2, 2015 ... mejora  de 7,9 meses en la supervivencia libre ... con cáncer colorrectal metastático inoperable (mCRC) tratados  en ... Y-90 más quimioterapia    Los beneficios ... directamente al hígado con la quimioterapia sistémica actual ...
(Date:6/1/2015)... June 2, 2015 Amgen (NASDAQ: ... on a Phase 1b study to evaluate the ... oncolytic immunotherapy, in combination with Roche,s investigational anti-PDL1 ... with triple-negative breast cancer and colorectal cancer with ... investigational oncolytic immunotherapy designed to selectively replicate in ...
(Date:6/1/2015)... , June 1, 2015   Regulus Therapeutics ... company leading the discovery and development of innovative ... G. Xanthopoulos , Ph.D. has resigned as President ... of Regulus, Board of Directors, effective today, to ... Grint, M.D., who previously served as Chief Medical ...
Breaking Medicine Technology:Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 3Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 4Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 5Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 6Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 7Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 8Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
... are anastomotic staplers available in four sizes ... lumen diameter. The staplers permit tissue attachment ... access and ease of use. The instruments ... by adjusting the height of the closed ...
ENDOPATH ILS Circular Sizer Set for ILS circular staplers. , ,The ILS Circular Sizer Set is intended to aid in selecting the appropriate size ILS Intraluminal Stapler for use in a variety of applica...
... to create an automatic purse-string with ... 45 disposable instrument has application in ... surgery for temporary and permanent purse-string ... disposable instrument has application in intestinal, ...
The Auto Suture™ EEA™ reusable stainless steel sizer set has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....
Medicine Products: